Flugue and colleagues [26] found that the EZH2 enzyme (a methyltransferase member of SET group) is frequently overexpressed in CRC samples and its high expression can be linked to better recurrence-free survival in CRC patients [25]. The gene discussed is EZH2; the disease is colorectal carcinoma.